All Type of News
Novartis Korea was nominated as a full member nation for ICRO
Novartis head office has nominated Novartis Korea as a full member unit for the ICRO (International Clinical Research Operations) of Novartis and decided to expand R&D investment for clinical research works of anti-ca...
Cancerous 22 hair dyes to be banned
Legal standards for a ban on cancer-inducing 22 hair dyes during a long-term use, including smoking cessation aids, will be established and go into effect in the first half of next year based on the EC Directive, the ...
DMF to ward off poor quality bulks.
The DMF system has blocked off an entry of poor quality bulk drugs from China and India.
Mr. Lee Joon-whan, a 5th grade officer of KFDA said in the drug regulatory review meeting on Dec. 22 on the subject of "The b...
Nanotechnolgy is key to Korea's successThe Korean Academy of Sciences and Technology (KAST) said on December 22 it held a symposium under the theme Current status and future prospects of Nanomedicine in Seoul Nationa...
|
Astrix price rises from 4,300 won to 7,700 won per 100 capsules
Boryung Pharm said the wholesaling price of Astrix (aspirin 100 mg capsule) has risen from 4,300 won to 7,700 won per 100 capsules from December 15, due to re-package formulation.
Astrix contains aspirin in an ente...
Taylor made medication may be soon realized.Prof. Oh Jeong-mi of SNU college of pharmacy found in a joint study with the U. S. NIH and U. S. FDA that a silent polymorphism without amino acid alteration could make changes ...
|
Who will take job as KPMA leader?
Considerable interest in selecting the next chairman of the Korea Pharmaceutical Manufacturers Association (KPMA), as the term of incumbent Chairman Huh Il-seob, chairman of Green Cross Corporation, ends in February n...
Very eventful 2006 to pharmacy circles.
An eventful 2006 to the pharmacy circle is now fading out slowly, leaving far bi-polar phenomenon behind in the prescription and non-prescription drug business to cause a lot of management difficulties with big change...
Anti-cancer drug, Genexol sold at over 10 billion won.
Genexol (paclitaxel), an anti-cancer drug, was developed by Samyang and distributed by CJ, now reaching its sales to 10 billion won at the early of Dec., which may achieve 11 billion won up the end of this year.
...
New business area, a priority for LG Life Sciences
LG Life Sciences will continue to adopt growth strategies next year, focusing on developing new business models.
To that end, the company said on December 21 it appointed two new business heads, Hwang Chang-hyun (s...
